Oral Rinses in Growth Inhibition and Treatment of Helicobacter Pylori Infection

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2020 Mar 6

PMID 32131741

Citations 15

Authors

Dharmendra Kashyap

Budhadev Baral

Tarun Prakash Verma

Charu Sonkar

Debi Chatterji

Ajay Kumar Jain

Hem C Jha

Affiliations

Soon will be listed here.

Abstract

Background: Helicobacter pylori (H. pylori) is well-known for its role in chronic gastritis and gastric cancer. Eradication of these carcinogenic bacteria from the gut is one of the challenges for clinicians. The complexity of treatment mainly owes to antibiotic resistance and relapse due to an additional reservoir in the oral cavity. Our study emphases the isolation of H. pylori from distinct habitats of the gut microenvironment (gastric biopsy and gastric juice) and its subsequent characterization. We have also evaluated the effect of various oral rinses on isolated H. pylori from different anatomical locations of included subjects.

Results: The possible strains isolated from two different habitats of the same subject shows a striking difference in their growth pattern. Promisingly, some of the included oral rinses are efficient in growth inhibition as per recommended 30 s treatment. The subsequent evaluation shows that oral rinse B (among A-E) is most effective and down-regulates the expression of one of the potent H. pylori gene, CagA, in the infected gastric adenocarcinoma (AGS) cells.

Conclusion: Our study, for the first time, revealed that H. pylori, isolated from the different habitat of the same subject, show a different growth pattern. The expression of H. pylori pathogenic gene (CagA) was down-regulated by the use of oral rinses. Hence, oral rinses will reduce the H. pylori in the oral cavity and help to control its migration from oral to the gastric compartment and may be used as an adjuvant treatment option for its re-infection.

Citing Articles

The role of in augmenting the severity of SARS-CoV-2 related gastrointestinal symptoms: An insight from molecular mechanism of co-infection.

Tandon A, Baral B, Saini V, Kandpal M, Dixit A, Parmar H Heliyon. 2024; 10(18):e37585.

PMID: 39364240 PMC: 11447314. DOI: 10.1016/j.heliyon.2024.e37585.

Helicobacter pylori in oral cavity: current knowledge.

Costa L, Carvalho M, Vale F, Marques A, Rasmussen L, Chen T Clin Exp Med. 2024; 24(1):209.

PMID: 39230790 PMC: 11374826. DOI: 10.1007/s10238-024-01474-1.

Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression.

Wongsuwanlert M, Teanpaisan R, Ruangsri P, Kaewdech A, Sunpaweravong S, Pahumunto N J Dent Sci. 2024; 19(3):1748-1757.

PMID: 39035281 PMC: 11259724. DOI: 10.1016/j.jds.2023.10.010.

Oral Hygiene With Neutral Electrolyzed Water and Systemic Therapy Increases Gastric Helicobacter pylori Eradication and Reduces Recurrence.

Urrutia-Baca V, Paz-Michel B, Calderon-Porras A, Valle J, Alvarez-Fernandez W, Mervitch-Sigal N Clin Exp Dent Res. 2024; 10(4):e927.

PMID: 38973212 PMC: 11228356. DOI: 10.1002/cre2.927.

Novel MAXPOWER biological antibacterial liquid for eradicating oral Helicobacter pylori.

Lai Y, Dong X, Song Y, Zhao J, Du Y, Li Z BMC Infect Dis. 2024; 24(1):540.

PMID: 38811871 PMC: 11137934. DOI: 10.1186/s12879-024-09424-8.

References

Ramakrishna B . Helicobacter pylori infection in India: the case against eradication. Indian J Gastroenterol. 2006; 25(1):25-8. View

Anand P, Nandakumar K, Shenoy K . Are dental plaque, poor oral hygiene, and periodontal disease associated with Helicobacter pylori infection?. J Periodontol. 2006; 77(4):692-8. DOI: 10.1902/jop.2006.050163. View

Zaric S, Bojic B, Jankovic L, Dapcevic B, Popovic B, Cakic S . Periodontal therapy improves gastric Helicobacter pylori eradication. J Dent Res. 2009; 88(10):946-50. DOI: 10.1177/0022034509344559. View

Backert S, Clyne M, Tegtmeyer N . Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun Signal. 2011; 9:28. PMC: 3266215. DOI: 10.1186/1478-811X-9-28. View

Shirin H, Moss S . Helicobacter pylori induced apoptosis. Gut. 1998; 43(5):592-4. PMC: 1727312. DOI: 10.1136/gut.43.5.592. View

Hooi J, Lai W, Ng W, Suen M, Underwood F, Tanyingoh D . Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153(2):420-429. DOI: 10.1053/j.gastro.2017.04.022. View

Jones C . Chlorhexidine: is it still the gold standard?. Periodontol 2000. 1998; 15:55-62. DOI: 10.1111/j.1600-0757.1997.tb00105.x. View

Ghoshal U, Tiwari S, Dhingra S, Pandey R, Ghoshal U, Tripathi S . Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008; 53(5):1215-22. DOI: 10.1007/s10620-008-0229-7. View

Sankaranarayanan R, Ramadas K, Qiao Y . Managing the changing burden of cancer in Asia. BMC Med. 2014; 12:3. PMC: 4029284. DOI: 10.1186/1741-7015-12-3. View

10.

Kauser F, Hussain M, Ahmed I, Ahmad N, Habeeb A, Khan A . Comparing genomes of Helicobacter pylori strains from the high-altitude desert of Ladakh, India. J Clin Microbiol. 2005; 43(4):1538-45. PMC: 1081395. DOI: 10.1128/JCM.43.4.1538-1545.2005. View

11.

Graham D, Lu H, Yamaoka Y . African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009; 10(2):77-84. PMC: 2846403. DOI: 10.1111/j.1751-2980.2009.00368.x. View

12.

Pourhoseingholi M, Vahedi M, Baghestani A . Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench. 2015; 8(1):19-27. PMC: 4285928. View

13.

Blanchard T, Nedrud J . Laboratory maintenance of Helicobacter species. Curr Protoc Microbiol. 2012; Chapter 8:Unit8B.1. DOI: 10.1002/9780471729259.mc08b01s24. View

14.

Singh K, Ghoshal U . Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol. 2006; 12(9):1346-51. PMC: 4124308. DOI: 10.3748/wjg.v12.i9.1346. View

15.

Porras-Hurtado L, Ruiz Y, Santos C, Phillips C, Carracedo A, Lareu M . An overview of STRUCTURE: applications, parameter settings, and supporting software. Front Genet. 2013; 4:98. PMC: 3665925. DOI: 10.3389/fgene.2013.00098. View

16.

Gebara E, Faria C, Pannuti C, Chehter L, Mayer M, Lima L . Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy. J Clin Periodontol. 2006; 33(5):329-33. DOI: 10.1111/j.1600-051X.2006.00915.x. View

17.

Jha H, Lu J, Saha A, Cai Q, Banerjee S, Prasad M . EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases. J Virol. 2013; 87(22):12121-38. PMC: 3807909. DOI: 10.1128/JVI.02379-13. View

18.

Backert S, Tegtmeyer N, Fischer W . Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015; 10(6):955-65. PMC: 4493163. DOI: 10.2217/fmb.15.32. View

19.

Guo J, Li S, Guo G . Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Dig Dis Sci. 2017; 62(8):2004-2010. DOI: 10.1007/s10620-017-4584-0. View

20.

Ribble D, Goldstein N, Norris D, Shellman Y . A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005; 5:12. PMC: 1142306. DOI: 10.1186/1472-6750-5-12. View